tirzepatide pregnancy risks and GLP-1 Peptide Drugs Are Now

For patients with severe hyperglycemia at diagnosis, tirzepatide monotherapy can achieve glycemic targets that might otherwise require combination therapy

Once breastfeeding is complete, tirzepatide can be safely reintroduced

Once stable at a therapeutic dose, additional compounds can be reintroduced one at a time

In May, the US president told reporters that a friend in London had told him he had bought the fat-shot drug for $88, compared with $1,300 in New York

When prescribed as part of a supervised program, GLP-1 therapies may help support steadier eating patterns, improved fullness cues, and long-term lifestyle changes

[1] Currently, Mounjaro is the only licensed weight loss treatment available that contains both types of receptor agonist